| Vol. 17.10 – 16 March, 2022 |
| |
|
|
| Researchers identified a non-canonical tricarboxylic acid (TCA) cycle that was required for changes in cell state. During exit from pluripotency, ESCs switched from canonical to non-canonical TCA-cycle metabolism. [Nature] |
|
|
|
| PUBLICATIONSRanked by the impact factor of the journal |
|
|
|
| The authors reported that iPSCs reprogramed from CD62L+ naive and memory T cells followed by CD19-CAR engineering and 3D-organoid system differentiation conferred products with conventional CD8αβ-positive CAR T cell characteristics. [Cell Stem Cell] |
|
|
|
| By targeting 1,700 transcription factors with CRISPR loss-of-function screen, researchers found that ZBTB11 and ZFP131 were required for ESC pluripotency. [Cell Reports] |
|
|
|
| Scientists used cerebral organoids derived from patients and genome edited-iPSCs to address pathophysiological changes associated with a complex malformation of human cortical development caused by mutations in the echinoderm microtubule-associated protein-like 1 (EML1) gene. [EMBO Reports] |
|
|
|
| By screening a fluorescent probe library, investigators found that intracellular glycogen led to specific reactivity to CDg4, a glycogen fluorescence sensor, in both human and mouse naïve ESCs. [Metabolic Engineering] |
|
|
|
| The authors generated ten O-negative hiPSC clones and evaluated their potential for mesoderm formation and erythroid differentiation, then used a perfusion bioreactor system to perform studies with high-density cultures of erythroblasts in vitro. [Cell Proliferation] |
|
|
|
| Researchers generated iPSC-derived hepatocytes and iPSC-derived cholangiocytes cells and characterized them based on hepatocyte-specific and cholangiocyte-specific markers. [Hepatology Communications] |
|
|
|
| The authors established a robust method allowing rapid derivation of mesenchymal stem cells from both human iPSCs and ESCs via a temporal induction of neural ectoderm in chemically defined media. [Cell & Bioscience] |
|
|
|
| To identify embryotoxic compounds, scientists developed an hiPSC-based biomarker assay based on the differentiation of hiPSCs into functional cardiomyocytes and hepatocytes. [Birth Defects Research] |
|
|
|
| Researchers reported that depletion of Jmjd6 not only resulted in downregulation of pluripotency genes, but was also implicated in apoptosis, glycolysis, cell cycle and protein hydroxylation. [Heliyon] |
|
|
|
|
| Scientists describe how differentiation of hiPSCs to specialized cardiac cellular identities facilitates our understanding of the development and pathogenesis of congenital heart disease subtypes. [Birth Defects Research] |
|
|
|
| The authors indicate that GD3 synthase contributes to gefitinib resistance in epidermal growth factor receptor-positive breast cancer cells, and is a potentially useful therapeutic target in drug-resistant breast cancers. [Glycoconjugate Journal] |
|
|
|
|
| Promega Corporation and FUJIFILM Cellular Dynamics, Inc., a leading global developer and manufacturer of human iPSC technologies, announced a strategic collaboration to advance novel assay development for drug discovery. [Promega Corporation] |
|
|
|
| I Peace, Inc. announced that the company had tripled its capacity to manufacture GMP grade iPSCs and iPSC-derived differentiated cells by expanding its facility. [I Peace, Inc. (Cision US, Inc.)] |
|
|
|
|
| May 19 – 22, 2022 Cancun, Mexico |
|
|
|
|
|
| Genentech, Inc. – South San Francisco, California, United States |
|
|
|
| Aspect Biosystems – Vancouver, British Columbia, Canada |
|
|
|
| University of Copenhagen – Copenhagen, Denmark |
|
|
|
| NIH National Heart, Lung, and Blood Institute – Bethesda, Maryland, United States |
|
|
|
| Oregon Health and Science University – Portland, Oregon, United States |
|
|
|
|